Trial Profile
Influence of switching from tenofovir disoproxil fumarate to tenofovir alafenamide containing ART on BMI and atherosclerotic cardiovascular disease in patients with HIV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2019
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Antiretrovirals; Tenofovir disoproxil fumarate
- Indications Atherosclerosis; Cardiovascular disorders; HIV infections
- Focus Therapeutic Use
- 19 Dec 2019 New trial record